
National Peroxide Ltd Upgraded to Buy on Improved Technicals and Attractive Valuation
2026-05-19 09:08:43National Peroxide Ltd has seen its investment rating upgraded from Hold to Buy, driven by a combination of improved technical indicators, attractive valuation metrics, and a positive financial trend. The micro-cap commodity chemicals company’s recent performance and outlook have prompted analysts to revise their assessment, reflecting growing investor confidence amid a challenging sector backdrop.
Read MoreBoard Meeting Intimation for Approval Of Financial Results
09-Aug-2026 | Source : BSENational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve i. Revised Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and Revised Audited Financial Statements for the financial year ended March 31 2026
Cancellation of Board Meeting
02-Aug-2026 | Source : BSEThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
Board Meeting Intimation for Approval Of Unaudited Financial Results For Quarter Ended 30Th June 2026.
29-Jul-2026 | Source : BSENational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
Corporate Actions
No Upcoming Board Meetings
National Peroxide Ltd has declared 125% dividend, ex-date: 20 Aug 24
No Splits history available
No Bonus history available
No Rights history available